raubasine has been researched along with almitrine in 27 studies
| Studies (raubasine) | Trials (raubasine) | Recent Studies (post-2010) (raubasine) | Studies (almitrine) | Trials (almitrine) | Recent Studies (post-2010) (almitrine) |
|---|---|---|---|---|---|
| 140 | 8 | 22 | 511 | 130 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (40.74) | 18.7374 |
| 1990's | 14 (51.85) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaboldi, R; Geroldi, D; Ghigini, B; Gorini, A; Villa, RF | 1 |
| Benzi, G; Curti, D | 1 |
| Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C | 1 |
| Guez, D | 1 |
| Cattelin, F; Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Guez, D; Malbezin, M; Schatz, C; Sebban, C; Tesolin, B | 1 |
| Allain, H; Bentué-Ferrer, D; Decombe, R; Reymann, JM; Schatz, C | 1 |
| Carbonin, PU; Cattelin, F; Gemma, A; Greco, A; Pisanti, P | 1 |
| Berthaux, P; Coulomb, B; Sebban, C; Tesolin, B | 1 |
| Benvenuti, C; Degos, JD; Gherardi, R; Lejonc, JL; Louarn, F; Perrier, M; Schaeffer, A | 1 |
| Pastoris, O; Villa, RF | 1 |
| Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Guez, D; Sebban, C; Tesolin, B | 1 |
| Azzaro, E; Fichera, G; Rapisarda, V | 1 |
| Borzeix, MG; Cahn, J | 1 |
| Cahn, J; Cahn, R | 1 |
| Meyer, B | 1 |
| Berthaux, P; Sebban, C | 1 |
| Callis, A; Dorance, M; Magnan de Bornier, B | 1 |
| Chan, P; Guez, D; Hu, P; Li, Y; Sarbach, SD; Zheng, Z | 1 |
| Debure, L; Ginovart, N; Pujol, JF; Rousset, C; Weissmann, D | 1 |
| Chan, P | 1 |
| Sebban, C | 1 |
| Laurent, B; Poitrenaud, J; Sebban, C | 1 |
| Allain, H; Bentué-Ferrer, D | 1 |
| El-Sayed, MA | 1 |
4 review(s) available for raubasine and almitrine
| Article | Year |
|---|---|
A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
Topics: Aged; Aging; Almitrine; Animals; Drug Combinations; Electroencephalography; Humans; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Humans; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
Topics: Almitrine; Animals; Brain Ischemia; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Treatment Outcome; Yohimbine | 1995 |
Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
Topics: Aging; Almitrine; Animals; Brain; Cerebrovascular Disorders; Drug Combinations; Electroencephalography; Humans; Neuroprotective Agents; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
6 trial(s) available for raubasine and almitrine
| Article | Year |
|---|---|
Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
Topics: Aged; Aged, 80 and over; Almitrine; Anxiety; Cognition Disorders; Depression; Double-Blind Method; Drug Combinations; Female; Humans; Male; Memory; Psychological Tests; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
[Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
Topics: Aged; Almitrine; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System Stimulants; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Piperazines; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1987 |
[A multicenter study of tinnitus. Epidemiology and therapy].
Topics: Almitrine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nicergoline; Piperazines; Plant Extracts; Random Allocation; Secologanin Tryptamine Alkaloids; Tinnitus; Yohimbine | 1986 |
[Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
Topics: Almitrine; Arteries; Drug Combinations; Humans; Middle Aged; Oxygen; Physical Exertion; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1983 |
Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Drug Combinations; Family Practice; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
17 other study(ies) available for raubasine and almitrine
| Article | Year |
|---|---|
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus.
Topics: Adaptation, Physiological; Almitrine; Animals; Energy Metabolism; Hippocampus; Male; Mitochondria; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1991 |
Role of synaptosomal enzymatic alterations and drug treatment in brain aging.
Topics: Aging; Almitrine; Animals; Brain; Citrate (si)-Synthase; Electron Transport Complex IV; Glucosephosphate Dehydrogenase; Male; Papaverine; Phosphofructokinase-1; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1990 |
Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
Topics: Aged; Aging; Almitrine; Cognition Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1990 |
Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
Topics: Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Pilot Projects; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1990 |
Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
Topics: Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Injections, Intraperitoneal; Male; Piperazines; Random Allocation; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Yohimbine | 1989 |
Peripheral neuropathy in patients treated with almitrine dimesylate.
Topics: Aged; Almitrine; Biopsy; Body Weight; Central Nervous System Stimulants; Drug Therapy, Combination; Evoked Potentials; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Peroneal Nerve; Piperazines; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1985 |
[Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
Topics: Adenosine Triphosphate; Aging; Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Central Nervous System Stimulants; Glucose; Hypoglycemia; Male; Phosphocreatine; Piperazines; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Sodium Chloride; Time Factors; Yohimbine | 1987 |
[Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
Topics: Acute Disease; Aged; Almitrine; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Central Nervous System Stimulants; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1987 |
[Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System Stimulants; Cerebral Cortex; Clonidine; Dementia; Drug Combinations; Drug Evaluation; Electroencephalography; Humans; Piperazines; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1987 |
Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Brain; Central Nervous System Stimulants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Ischemic Attack, Transient; Male; Necrosis; Piperazines; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Water-Electrolyte Balance; Yohimbine | 1987 |
Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
Topics: Almitrine; Animals; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Dogs; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Piperazines; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1988 |
[Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
Topics: Almitrine; Animals; Diphosphoglyceric Acids; Erythrocytes; Hypoxia; Kinetics; Oxygen; Partial Pressure; Piperazines; Rabbits; Secologanin Tryptamine Alkaloids; Triazines; Yohimbine | 1980 |
Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Brain; Brain Chemistry; Brain Ischemia; Cats; Cerebral Arteries; Female; Glycogen; Male; Mitochondria; Secologanin Tryptamine Alkaloids; Yohimbine | 1993 |
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
Topics: Almitrine; Animals; Carotid Artery Diseases; Constriction; Drug Combinations; Gerbillinae; Glial Fibrillary Acidic Protein; Hippocampus; Ischemic Attack, Transient; Male; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
[Effect of almitrine/raubasine on cerebral metabolism in the elderly].
Topics: Aged; Almitrine; Alzheimer Disease; Animals; Brain; Brain Ischemia; Energy Metabolism; Humans; Neurons; Nootropic Agents; Oxygen Consumption; Secologanin Tryptamine Alkaloids; Yohimbine | 2002 |
Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
Topics: Almitrine; Drug Combinations; Drug Stability; Methanol; Respiratory System Agents; Secologanin Tryptamine Alkaloids; Solvents; Spectrophotometry; Vasodilator Agents | 2009 |